Natalia Kunst

Bilde av Natalia Kunst
English version of this page
E-post natalia.kunst@medisin.uio.no
Brukernavn
Besøksadresse Forskningsveien 3A Harald Schjelderups hus 0373 Oslo
Postadresse Postboks 1089 Blindern 0317 Oslo

Faglige interesser

Beslutningsanalytisk modellering, kostnadseffektivitetsanalyser, value of information (VOI), helseøkonomisk evaluering, matematisk modellering, Bayesianske metoder og beslutningsteori, kausal inferens.

Undervisning

  • Høst 2019 -  Teaching Fellow for the graduate-level course Cost-Effectiveness Analysis and Decision Making [HPM 570], Yale University School of Public Health, Course Faculty: A. David Paltiel
  • Vår 2019 - Teaching Fellow for Advanced Topics in Decision-making in Medicine [EWP02], Erasmus Medical Center, Course Faculty: Myriam Hunink

Bakgrunn

  • 2019 – Postgraduate Research Fellow, Yale University School of Medicine
  • 2018 –   Visiting PhD Candidate, Public Health Modeling Unit Yale University School of Public Health
  • 2017 –   Doktorgradsstipendiat i helseøkonomisk evaluering, Universitetet i Oslo
  • 2017 –   PhD Research Fellow, Decision Modeling Center VUmc Amsterdam
  • 2015 –   Senior Helseøkonom, LINK Medical Research, Oslo
  • PhD-kurs og forskningsaktiviteter, Department of Economics, Gdansk University of Technology, 2011-2013  
  • MSc, Department of Economics, Gdansk University of Technology, 2011
  • MSc, Department of Economics and Economic Policy, Gdynia University, 2011

Priser

  • Gullmedalje for fremragende akademiske resultater og forskning i løpet av mastergraden utdelt av Rektoren ved Gdansk University of Technology.

  • Pris for beste masteroppgave i arbeidsøkonomi utdelt av Labor Office in Gdansk.

Samarbeid

Emneord: Helseøkonomi, Økonomisk evaluering

Publikasjoner

  • Tuffaha, Haitham; Rothery, Claire; Kunst, Natalia; Jackson, Chris; Strong, Mark & Birch, Stephen (2021). A Review of Web-Based Tools for Value-of-Information Analysis. Applied Health Economics and Health Policy. ISSN 1175-5652. 19(5), s. 645–651. doi: 10.1007/s40258-021-00662-4.
  • Kunst, Natalia; Long, Jessica; Xu, Xiao; Busch, Susan; Kyanko, Kelly & Lindau, Stacy T. [Vis alle 8 forfattere av denne artikkelen] (2021). Understanding Regional Variation in the Cost of Breast Cancer Screening among Privately Insured Women in the United States. Medical Care. ISSN 0025-7079. 59(5), s. 437–443. doi: 10.1097/MLR.0000000000001506.
  • Kunst, Natalia; Wang, Shi-Yi; Hood, Annette; Mougalian, Sarah; DiGiovanna, Michael & Adelson, Kerin [Vis alle 7 forfattere av denne artikkelen] (2020). Cost-Effectiveness of Neoadjuvant-Adjuvant Treatment Strategies for Women With ERBB2(HER2)–Positive Breast Cancer. JAMA Network Open. ISSN 2574-3805. doi: 10.1001/jamanetworkopen.2020.27074.
  • Kunst, Natalia; Alarid-Escudero, Fernando; Aas, Eline; Coupe, Veerle; Schrag, Deborah & Kuntz, Karen (2020). Estimating population-based recurrence rates of colorectal cancer over time in the United States. Cancer Epidemiology, Biomarkers and Prevention. ISSN 1055-9965. 29(12), s. 2710–2718. doi: 10.1158/1055-9965.EPI-20-0490.
  • Kim, David D.; Silver, Madison C.; Kunst, Natalia; Cohen, Joshua T.; Ollendorf, Daniel A. & Neumann, Peter J. (2020). Perspective and Costing in Cost-Effectiveness Analysis, 1974–2018. PharmacoEconomics (Auckland). ISSN 1170-7690. doi: 10.1007/s40273-020-00942-2.
  • Kunst, Natalia; Wilson, Edward C.F.; Glynn, David; Alarid-Escudero, Fernando; Baio, Gianluca & Brennan, Alan [Vis alle 14 forfattere av denne artikkelen] (2020). Computing the Expected Value of Sample Information Efficiently: Practical Guidance and Recommendations for Four Model-Based Methods. Value in Health. ISSN 1098-3015. 23(6), s. 734–742. doi: 10.1016/j.jval.2020.02.010.
  • Heath, Anna; Kunst, Natalia; Jackson, Christopher; Strong, Mark; Alarid-Escudero, Fernando & Goldhaber-Fiebert, Jeremy D. [Vis alle 9 forfattere av denne artikkelen] (2020). Calculating the Expected Value of Sample Information in Practice: Considerations from 3 Case Studies. Medical decision making. ISSN 0272-989X. doi: 10.1177/0272989X20912402.
  • Kunst, Natalia; Long, Jessica; Xu, Xiao; Busch, Susan; Kyanko, Kelly & Richman, Ilana [Vis alle 7 forfattere av denne artikkelen] (2020). Use and Costs of Breast Cancer Screening for Women in Their 40s in a US Population With Private Insurance. JAMA Internal Medicine. ISSN 2168-6106. doi: 10.1001/jamainternmed.2020.0262.
  • Kunst, Natalia R.; Alarid-Escudero, Fernando; Paltiel, A. David & Wang, Shi-Yi (2019). A value of information analysis of research on the 21-gene assay for breast cancer management. Value in Health. ISSN 1098-3015. 22(10), s. 1102–1110. doi: 10.1016/j.jval.2019.05.004.
  • Kunst, Natalia R.; Lindvik, Helene; Carlsen, Kai-Håkon; Håland, Geir; Jørgensen, Eivind & Carlsen, Karin C. Lødrup (2019). Cost-effectiveness of diagnostic algorithms for peanut allergy in children. Journal of Allergy and Clinical Immunology. ISSN 0091-6749. 143(3), s. 1243–1246. doi: 10.1016/j.jaci.2018.10.050.

Se alle arbeider i Cristin

  • Kim, David D.; Silver, Madison C.; Kunst, Natalia; Cohen, Joshua T.; Ollendorf, Daniel A. & Neumann, Peter J. (2020). Correction to: Perspective and Costing in Cost‑Effectiveness Analysis, 1974–2018 (PharmacoEconomics, (2020), 38, 10, (1135-1145), 10.1007/s40273-020-00942-2). PharmacoEconomics (Auckland). ISSN 1170-7690. 38(12). doi: 10.1007/s40273-020-00968-6.
  • Byrne, Jennifer & Kunst, Natalia (2020). Mammography for women aged 40 to 49 years associated with high, widely variable costs. [Internett]. Healio.
  • Kunst, Natalia & Mamoun, Fred (2020). Breast Cancer Screening Costs High, Benefits Uncertain, for Women in 40s. [Internett]. Yale News.
  • Dunleavy, Brian P. & Kunst, Natalia (2020). Less than half of women in their 40s screened for breast cancer each year. [Internett]. United Press International.
  • Kunst, Natalia (2020). Quantifying the value of further research to improve 21-gene assay decision-making in breast cancer.
  • Kunst, Natalia (2020). Value of Information analysis in medical decision making.
  • Kunst, Natalia & Gross, Cary (2020). Breast Cancer Screening and Health Care Costs—Reply. JAMA Internal Medicine. ISSN 2168-6106. doi: 10.1001/jamainternmed.2020.2355.
  • Furlow, Bryant & Kunst, Natalia (2019). All Women with Breast Cancer Should Undergo Multigene Testing, Study Suggests. [Tidsskrift]. Cancer Network.
  • Kunst, Natalia; Wang, Shi-Yi; Hood, Annette; Mougalian, Sarah; DiGiovanna, Michael & Adelson, Kerin [Vis alle 7 forfattere av denne artikkelen] (2019). Cost-effectiveness of different neoadjuvant followed by adjuvant treatment strategies for women with HER2-positive breast cancer (Spotlight Session).
  • Kunst, Natalia (2019). Finding the optimal diagnostic algorithm for children with peanut allergy: A cost-effectiveness study.
  • Kunst, Natalia (2019). Diagnosing peanut allergy in children: A cost-effectiveness analysis of diagnostic algorithms.
  • Kunst, Natalia; Grosse, Scott; Chen, Yao-Hsuan; Kim, David & Wisløff, Torbjørn (2019). Overview of various recommendations for health economic perspective. Symposium: Value for whom? Choice and Consequences of Perspective in Economic Evaluations.
  • Kunst, Natalia; Long, Jessica; Xu, Xiao; Busch, Susan; Kyanko, Kelly & Richman, Ilana [Vis alle 7 forfattere av denne artikkelen] (2019). Utilization and costs of breast cancer screening for women in their 40s in a privately insured US population.
  • Kunst, Natalia; Wilson, Ed; Alarid-Escudero, Fernando; Baio, Gianluca; Brennan, Alan & Fairley, Michael [Vis alle 14 forfattere av denne artikkelen] (2019). Practical Considerations for the Efficient Computation of the Expected Value of Sample Information to Prioritize Research in Health Care.
  • Kunst, Natalia; Alarid-Escudero, Fernando; Aas, Eline; Coupe, Veerle & Kuntz, Karen (2019). Real-World Recurrence Rates of Colorectal Cancer over Time.
  • Kunst, Natalia R. (2019). A comprehensive value of information analysis to assess the state of the evidence and quantify uncertainty on the use of 21-gene assay Oncotype DX.
  • Kunst, Natalia R. (2018). Future research on the 21-gene assay for breast cancer: A value of information analysis.
  • Kunst, Natalia R. (2018). What is the value of further research on the 21-gene assay for breast cancer management?
  • Kunst, Natalia R.; Lindvik, Helene; Carlsen, Kai-Håkon; Håland, Geir; Jørgensen, Eivind & Carlsen, Karin C. Lødrup (2018). Diagnosing Peanut Allergy in Children: A Cost-Effectiveness Analysis of Diagnostic Algorithms.
  • Kunst, Natalia R.; Alarid-Escudero, Fernando & Wang, Shi-Yi (2018). Decisions on Further Research for 21-Gene Assay in Real-World Management of Breast Cancer: A Value of Information Analysis. [Lee B. Lusted Award Finalist].
  • Kunst, Natalia R. (2017). Health economic modeling to determine the optimal diagnostic algorithm for nut allergy.

Se alle arbeider i Cristin

Publisert 4. jan. 2018 14:00 - Sist endret 25. aug. 2021 09:48

Forskergrupper